Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SYK compared with RCEL: revenue, margins and what each company keeps, and the suppliers and customers both name
SYK
Stryker Corp
Change
Mkt cap
Revenue
Revenue
RCEL
AVITA Medical, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SYK
Stryker Corp
vs
RCEL
AVITA Medical, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SYK, solid
RCEL, dashed
Supply-chain overlap
Revenue flow
RCEL: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SYK
1
UFPT
UFP Technologies
supplier
Shared
0
No shared counterparties.
Only RCEL
5
—
Collagen Matrix, Inc. dba Regenity Biosciences ("Regenity")
unlisted
supplier
—
Stedical Scientific, Inc. ("Stedical")
unlisted
supplier
—
Collagen Matrix, LLC d/b/a as Regenity Biosciences
unlisted
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
supplier
—
Biomedical Advanced Research and Development Authority ("BARDA")
unlisted
customer
1 more · RCEL chain
›
SYK
Stryker Corp
Change
339.80
· pre 340.48
· delayed
Mkt cap
$129.3B
Revenue
$6.5B
Q3 FY26
Revenue
$25.1B
FY25
RCEL
AVITA Medical, Inc.
Change
15.37
· pre 16.29
· delayed
Pre-market
Nov 5 '26
delayed
Mkt cap
$25.2M
Revenue
$22M
Q2 FY26
Revenue
$72M
FY25
vs
Compare
Pre-market
Nov 5 '26
delayed
SYK
Stryker Corp
vs
RCEL
AVITA Medical, Inc.
339.80
pre 340.48
delayed
Price
15.37
pre 16.29
delayed
$129.3B
Mkt cap
$25.2M
Q3 FY26
$6.5B
Revenue
$22M
Q2 FY26
FY25
$25.1B
Revenue
$72M
FY25
Change
Change
SYK
339.80
vs
RCEL
15.37
Pre-market
Nov 5 '26
delayed